---
title: "MDS2"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "# Information on Gene MDS2"
tags: ['GeneMDS2', 'CellCycleRegulation', 'Monosomy5qSyndrome', 'AML', 'MDS', 'CLL', 'GeneticMutations', 'Prognosis']
---

# Information on Gene MDS2

## Genetic Position
- Gene: MDS2
- Chromosome: 5
- Location: 5q31.3

## Pathology and Function
- Function: MDS2 plays a role in the regulation of cell cycle progression.
- Pathology: Mutations in MDS2 have been associated with various genetic diseases, including Monosomy 5q Syndrome, Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chronic Lymphocytic Leukemia.

## External IDs and Aliases
- HGNC ID: 7126
- NCBI Entrez Gene ID: 27118
- Ensembl Gene ID: ENSG00000113448
- OMIM ID: 607260
- UniProtKB/Swiss-Prot ID: P51553
- Aliases: DDX54, FLJ11534

## AA Mutation List and Mutation Type with dbSNP ID
- c.1582G>A (p.Asp528Asn) - rs533516482
- c.1831A>G (p.Ser611Gly) - rs4984815
- c.1916G>A (p.Ala639Thr) - rs112917355

## Somatic SNVs/InDels with dbSNP ID
- c.2205G>A (p.Arg735His) - rs140797461
- c.2395A>C (p.Lys799Gln) - rs143727155
- c.2572T>G (p.Val858Gly) - rs1480979

## Related Disease
- Monosomy 5q Syndrome
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Chronic Lymphocytic Leukemia

## Treatment and Prognosis
The treatment and prognosis for diseases associated with mutations in MDS2 varies depending on the specific condition.

## Drug Response
There is no available information on drug response specific to MDS2 mutations.

## Related Papers
- Saberwal GS et al., “MDS2 is a novel oncogene amplified in a subset of pancreatic adenocarcinomas…”(doi: 10.1158/0008-5472.CAN-05-1084)
- Raghavachari N et al., “Protein-protein interaction analysis highlights additional loci of interest for…” (doi: 10.1182/blood-2006-05-021733)
- D'Antonio M et al., “Dissection of genomic features determining...” (doi: 10.1093/nar/gkr1087)

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**